Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-07-22
2008-07-22
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S300000, C530S303000
Reexamination Certificate
active
07402565
ABSTRACT:
A method is provided which allows high yields of acylated insulin. The method comprises expressing a singe-chain insulin precursor, preferably in yeast, cleaving the single-chain insulin precursor with a suitable protease which will open the peptide bond between the C-terminal amino group in the B-chain and a connecting peptide connecting the B chain with the A-chain, acylating the two-chain insulin intermediate in the ε-amino group in LysB29and subjecting the acylated two-chain insulin intermediate to a proteolytic enzyme which will cleave of the N-terminal extension on the B- and A-chains on the precursor molecule.
REFERENCES:
patent: 5646242 (1997-07-01), Baker et al.
patent: 5693609 (1997-12-01), Baker et al.
patent: 5750497 (1998-05-01), Havelund et al.
patent: 5905140 (1999-05-01), Hansen
patent: 5922675 (1999-07-01), Baker et al.
patent: 6011007 (2000-01-01), Havelund et al.
patent: RE37971 (2003-01-01), Baker et al.
patent: 163529 (1985-05-01), None
patent: 792290 (1994-09-01), None
patent: 1132404 (1994-09-01), None
patent: 712862 (1995-11-01), None
patent: 894095 (1997-02-01), None
patent: 96/29344 (1996-03-01), None
patent: 98/02460 (1997-07-01), None
patent: WO 02/079250 (2002-10-01), None
patent: 03/010186 (2003-02-01), None
Kjeldsen, T—Appl Microbiol Biotechnol—2000—vol. 54—pp. 277-286.
Kjeldsen, T et al—Prot Expres Purif—1998—vol. 14—pp. 309-316.
Kjeldsen, T et al—Gene—1996—vol. 170—pp. 107-110.
Kjeldsen Thomas Børglum
Markussen Jan
Gupta Anish
Ha Julie
Novo Nordisk A S
Walker Shelby J.
LandOfFree
Processes for making acylated insulin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Processes for making acylated insulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Processes for making acylated insulin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2812412